PKM and melanoma: PKM2 displayed similar expression patterns, and its knockout had similar phenotypic results in tumor-specific T cells in both a non-small cell lung cancer model and a melanoma model, suggesting a conserved mechanistic response regardless of tumor type, although with potential differences in kinetics and magnitude.